[
  {
    "ts": null,
    "headline": "Why Pfizer Inc. (PFE) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom",
    "summary": "We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best pharma stocks to invest in now amid the domestic manufacturing boom. Trump Incentivizes Pharmaceuticals to Build Domestic Manufacturing Capacity […]",
    "url": "https://finnhub.io/api/news?id=b2f1f7744af091ef42189b3560aa94bdd8585ad6610182aca0a453d5451b4a3e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747170447,
      "headline": "Why Pfizer Inc. (PFE) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom",
      "id": 134461056,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best pharma stocks to invest in now amid the domestic manufacturing boom. Trump Incentivizes Pharmaceuticals to Build Domestic Manufacturing Capacity […]",
      "url": "https://finnhub.io/api/news?id=b2f1f7744af091ef42189b3560aa94bdd8585ad6610182aca0a453d5451b4a3e"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Dissolves Share Stake In Akero Therapeutics",
    "summary": "Pfizer: * PFIZER DISSOLVES SHARE STAKE IN AKERO THERAPEUTICS- SECFILINGFurther company coverage: ...",
    "url": "https://finnhub.io/api/news?id=1092a961e9b219ff72a69bd3fd82d0dac0257874b65772ccdb3363d1b0f8e9b2",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747155187,
      "headline": "Pfizer Dissolves Share Stake In Akero Therapeutics",
      "id": 134413669,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Pfizer: * PFIZER DISSOLVES SHARE STAKE IN AKERO THERAPEUTICS- SECFILINGFurther company coverage: ...",
      "url": "https://finnhub.io/api/news?id=1092a961e9b219ff72a69bd3fd82d0dac0257874b65772ccdb3363d1b0f8e9b2"
    }
  },
  {
    "ts": null,
    "headline": "PFE vs. LLY: Which Stock Is the Better Value Option?",
    "summary": "PFE vs. LLY: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=a28081e22173114cd938b566a5a3e1fc156f30aff03d0735d71337463e1616d4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747150810,
      "headline": "PFE vs. LLY: Which Stock Is the Better Value Option?",
      "id": 134408462,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "PFE vs. LLY: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=a28081e22173114cd938b566a5a3e1fc156f30aff03d0735d71337463e1616d4"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump’s Executive Order.",
    "summary": "There are significant questions on how the order can be implemented, and if companies can raise prices on already approved drugs, analysts say.",
    "url": "https://finnhub.io/api/news?id=d33f465d744d98c002ff8009fcd14dd04cfb9c137a090ae62554c09b8767bd39",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747149480,
      "headline": "Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump’s Executive Order.",
      "id": 134408464,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "There are significant questions on how the order can be implemented, and if companies can raise prices on already approved drugs, analysts say.",
      "url": "https://finnhub.io/api/news?id=d33f465d744d98c002ff8009fcd14dd04cfb9c137a090ae62554c09b8767bd39"
    }
  },
  {
    "ts": null,
    "headline": "4 Value Picks to Ride the Market Rebound After US-China Trade Thaw",
    "summary": "Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. STNE, CNC, CVS & PFE boast a low P/CF ratio.",
    "url": "https://finnhub.io/api/news?id=8cc7f3b0ede0201eaa2826b461d98c532b17e02b89bd9b4fe00344d02192072d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747147020,
      "headline": "4 Value Picks to Ride the Market Rebound After US-China Trade Thaw",
      "id": 134409116,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. STNE, CNC, CVS & PFE boast a low P/CF ratio.",
      "url": "https://finnhub.io/api/news?id=8cc7f3b0ede0201eaa2826b461d98c532b17e02b89bd9b4fe00344d02192072d"
    }
  },
  {
    "ts": null,
    "headline": "Should Value Investors Buy Pfizer (PFE) Stock?",
    "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
    "url": "https://finnhub.io/api/news?id=bf5644c7e355f1521f81143a965a70d6b6febf0e00c46207609b1e6c8ab75cd9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747143615,
      "headline": "Should Value Investors Buy Pfizer (PFE) Stock?",
      "id": 134409118,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
      "url": "https://finnhub.io/api/news?id=bf5644c7e355f1521f81143a965a70d6b6febf0e00c46207609b1e6c8ab75cd9"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen",
    "summary": "J&J, Eli Lilly, Pfizer, Merck, Amgen are included in this Analyst Blog.",
    "url": "https://finnhub.io/api/news?id=320533a4eecb703b72d1f8b25b1eb735bf445b2d520cb9cffb5d6909392ca080",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747142520,
      "headline": "The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen",
      "id": 134408465,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "J&J, Eli Lilly, Pfizer, Merck, Amgen are included in this Analyst Blog.",
      "url": "https://finnhub.io/api/news?id=320533a4eecb703b72d1f8b25b1eb735bf445b2d520cb9cffb5d6909392ca080"
    }
  },
  {
    "ts": null,
    "headline": "Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared",
    "summary": "President Trump issues an executive order that will push drugmakers to offer prescription drugs to U.S. cash-pay consumers at lower prices.",
    "url": "https://finnhub.io/api/news?id=23bbeb15ae0717dfdb51c6a7609af3434ba7986e390b2ba72908dbe1393246e1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747136160,
      "headline": "Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared",
      "id": 134408470,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "President Trump issues an executive order that will push drugmakers to offer prescription drugs to U.S. cash-pay consumers at lower prices.",
      "url": "https://finnhub.io/api/news?id=23bbeb15ae0717dfdb51c6a7609af3434ba7986e390b2ba72908dbe1393246e1"
    }
  },
  {
    "ts": null,
    "headline": "PFE Q1 Earnings Call: Revenue Misses, Margin Expansion, and Focus on Pipeline Productivity",
    "summary": "Global pharmaceutical company Pfizer (NYSE:PFE) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 7.8% year on year to $13.72 billion. The company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.6% below analysts’ estimates. Its non-GAAP profit of $0.92 per share was 36.1% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=914ea191e22bd626a7e88b3e2735cc6ab985cd199d4a6f3365cb7e4787645a50",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747131683,
      "headline": "PFE Q1 Earnings Call: Revenue Misses, Margin Expansion, and Focus on Pipeline Productivity",
      "id": 134409123,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Global pharmaceutical company Pfizer (NYSE:PFE) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 7.8% year on year to $13.72 billion. The company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.6% below analysts’ estimates. Its non-GAAP profit of $0.92 per share was 36.1% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=914ea191e22bd626a7e88b3e2735cc6ab985cd199d4a6f3365cb7e4787645a50"
    }
  },
  {
    "ts": null,
    "headline": "What has Trump said about cutting drug prices?",
    "summary": "U.S. President Donald Trump signed abroad executive order on Monday directing drugmakers to lowerthe prices of their prescription drugs to align with what othercountries pay. The...",
    "url": "https://finnhub.io/api/news?id=aff485c254f450575502f17c3969bf98673c6811f9f2c394054b2056a43355dd",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747112112,
      "headline": "What has Trump said about cutting drug prices?",
      "id": 134397006,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "U.S. President Donald Trump signed abroad executive order on Monday directing drugmakers to lowerthe prices of their prescription drugs to align with what othercountries pay. The...",
      "url": "https://finnhub.io/api/news?id=aff485c254f450575502f17c3969bf98673c6811f9f2c394054b2056a43355dd"
    }
  }
]